Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3769553018 | Trastuzumab 440 mg powder for solution for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
3769554012 | Product containing precisely trastuzumab 440 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Trastuzumab 440 mg powder for solution for injection vial | Has BoSS | Trastuzumab | true | Inferred relationship | Some | 1 | |
Trastuzumab 440 mg powder for solution for injection vial | Has presentation strength numerator value | 440 | false | Inferred relationship | Some | 1 | |
Trastuzumab 440 mg powder for solution for injection vial | Has precise active ingredient | Trastuzumab | true | Inferred relationship | Some | 1 | |
Trastuzumab 440 mg powder for solution for injection vial | Is a | Trastuzumab only product in parenteral dose form | true | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 1 | |
Trastuzumab 440 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Trastuzumab 440 mg powder for solution for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Trastuzumab 440 mg powder for solution for injection vial | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Has unit of presentation | Vial | true | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Is a | Trastuzumab 150 mg powder for solution for injection vial | false | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Is a | Trastuzumab-containing product | false | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Has active ingredient | Murine-human monoclonal IgG antibody | false | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Has active ingredient | Biological agent | false | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Has active ingredient | Trastuzumab | false | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Has active ingredient | Monoclonal antibody | false | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Is a | Trastuzumab-containing product in parenteral dose form | false | Inferred relationship | Some | ||
Trastuzumab 440 mg powder for solution for injection vial | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets